Home > Healthcare > Healthcare IT > Artificial Intelligence > Cardiac AI Monitoring and Diagnostics Market

Cardiac AI Monitoring and Diagnostics Market Share

Report ID: GMI8858
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Cardiac AI Monitoring and Diagnostics Market Share

The cardiac AI monitoring and diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Cardiac AI Monitoring and Diagnostics Market Companies

Some of the eminent market participants operating in the industry include:

CardiAI
Cleerly, Inc.
DiA Imaging Analysis
HeartVista Inc.
IDOVEN
Koninklijke Philips N.V.
RSIP Vision
Tempus
Ultrasight
Ultromics Limited
Viz.ai, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Industry size for cardiac AI monitoring and diagnostics recorded USD 984.7 million in 2023 and is expected to register 26.9% CAGR from 2024 to 2032, owing to the growing prevalence of cardiovascular diseases, and rising focus on precision medicine.

The hardware segment of the cardiac AI monitoring and diagnostics industry is expected to accumulate USD 5 billion by 2032, due to the enhanced computational power of hardware tools like advanced processors, enabling real-time analysis of cardiac data.

North America industry accounted for USD 399.2 million in revenue in 2023 and is expected to expand at notable CAGR from 2024 to 2032, on account of the high rates of obesity, sedentary lifestyles, and an aging population.

CardiAI, Cleerly, Inc., DiA Imaging Analysis, HeartVista Inc., IDOVEN, Koninklijke Philips N.V., RSIP Vision, Tempus, Ultrasight, Ultromics Limited, Viz.ai, Inc. are some of the major cardiac AI monitoring and diagnostics companies worldwide.